|
Author
|
Guideline criteria used
|
Estimated prevalence (%)
|
|---|
|
IFG or IGT
|
IFG
|
IGT
|
IFG and IGT
|
HbA1C
|
HbA1C and IFG
|
|---|
|
Karve [22]
|
ADAa
|
19.8
|
4.5
|
11.8
|
3.5
|
–
|
–
|
|
ADA†
|
34.6
|
19.4
|
5.4
|
9.8
|
–
|
–
|
|
Yip [14]
|
ADA†
|
–
|
53.1
|
23.8
|
20.2
|
–
|
–
|
|
WHO
|
–
|
36.0
|
45.5
|
15.8
|
–
|
–
|
|
Blum [23]
|
ADA†
|
–
|
3.0
|
–
|
–
|
24.7
|
3.2
|
- a1997 guidelines, FPG: 6.1–6.9 mmol/L (110–125 mg/dL); †post 2003 guidelines, FPG: 5.6–6.9 mmol/L (100–125 mg/dL)
- ADA American Diabetes Association, FPG Fasting plasma glucose, HbA1C, glycated haemoglobin; IFG Impaired fasting glucose, IGT Impaired glucose tolerance, WHO World Health Organization
